EWTX · Edgewise Therapeutics, Inc.

$44.21 -0.51 (-1.14%) At close · Aug 25

Market Cap

$4.80B

108.60M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-06	—
10-Q	2026-08-06	2026-06-30
8-K/A	2026-07-16	2026-07-10
8-K	2026-07-13	2026-07-10
8-K	2026-06-05	2026-06-04
8-K	2026-06-01	2026-05-31
10-Q	2026-05-07	2026-03-31
8-K	2026-05-07	—
DEF 14A	2026-04-23	2026-06-04
8-K	2026-02-26	—
10-K	2026-02-26	2025-12-31
8-K	2025-11-20	2025-11-19
8-K	2025-11-10	—
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
10-Q	2025-08-07	2025-06-30
8-K	2025-08-07	—
8-K	2025-06-26	—
8-K	2025-05-08	—
10-Q	2025-05-08	2025-03-31
DEF 14A	2025-04-29	2025-06-13
8-K	2025-04-02	—
8-K	2025-04-02	—
10-K	2025-03-03	2024-12-31
8-K	2025-03-03	—
8-K	2025-01-22	2025-01-08
8-K	2024-12-16	—
10-Q	2024-11-07	2024-09-30
8-K	2024-11-07	—
8-K	2024-08-12	2024-08-10
10-Q	2024-08-08	2024-06-30
8-K	2024-08-08	—
8-K	2024-06-11	2024-06-07
8-K	2024-05-10	—
10-Q	2024-05-09	2024-03-31
8-K	2024-05-09	—
8-K	2024-05-07	2024-05-06
DEF 14A	2024-04-26	2024-06-07
8-K	2024-02-22	—
10-K	2024-02-22	2023-12-31
8-K	2024-01-19	—
8-K	2024-01-19	—
10-Q	2023-11-09	2023-09-30
8-K	2023-11-09	—
10-Q	2023-08-10	2023-06-30
8-K	2023-08-10	—
8-K	2023-07-14	2023-07-10
8-K	2023-06-22	2023-06-19
8-K	2023-06-16	2023-06-15
8-K	2023-06-12	2023-06-09

Showing 1–50 of 77 filings

Key facts CIK 1710072 CUSIP 28036F105 13F (30d) 205 filings 201 filers Visit website Investor relations